Proportion of Multidrug-Resistant Tuberculosis in Human Immunodeficiency Virus/Mycobacterium tuberculosis Co-Infected Patients in Korea

被引:5
作者
Joh, Joon Sung [2 ,3 ]
Hong, H. Christian [2 ]
Jeong, In A. [2 ,3 ]
Chin, Bum Sik [2 ,4 ]
Yang, Hye Jin [4 ]
Choi, Hongjo [5 ]
Bang, Ji Hwan [1 ]
机构
[1] Seoul Natl Univ, Div Infect Dis, Seoul Metropolitan Govt Boramae Med Ctr, Seoul 156707, South Korea
[2] Natl Med Ctr, Dept Internal Med, Seoul, South Korea
[3] Natl Med Ctr, Ctr Resp Dis, Seoul, South Korea
[4] Natl Med Ctr, Ctr Infect Dis, Seoul, South Korea
[5] Int TB Res Ctr, Chang Won, South Korea
关键词
Tuberculosis; Multidrug-Resistant Tuberculosis; HIV; MYCOBACTERIUM-TUBERCULOSIS; HIV;
D O I
10.3346/jkms.2012.27.10.1143
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Much controversy surrounds the issue of whether HIV infection is a risk factor for developing multidrug-resistant tuberculosis (MDR-TB). In this study, we evaluated the prevalence of and risk factors for MDR-TB in HIV-infected patients at the National Medical Center of Korea. We reviewed the medical records of HIV/TB co-infected patients from January 2005 to May 2011; the drug susceptibility profiles were available for 55 patients. Of these, 32.7% had MDR-TB, which was approximately 3.6 times higher than the prevalence among the general population. Additionally, there were more additional AIDS-defining clinical illnesses in the MDR-TB group than in the non-MDR-TB group (27.8% vs 5.4%, P = 0.032). These results suggest that HIV infection and HIV-related immunosuppresion may contribute to the development of MDR-TB.
引用
收藏
页码:1143 / 1146
页数:4
相关论文
共 15 条
[1]  
[Anonymous], 2006, MMWR Morbidity Weekly, V55, P1176
[2]  
[Anonymous], 1992, MMWR Recomm. Rep, V41
[3]   The evolution of drug resistance in Mycobacterium tuberculosis:: From a mono-rifampin-resistant cluster into increasingly multidrug-resistant variants in an HIV-seropositive population [J].
Bifani, Pablo ;
Mathema, Barun ;
Kurepina, Natalia ;
Shashkina, Elena ;
Bertout, Julie ;
Blanchis, Anne Sophie ;
Moghazeh, Soraya ;
Driscoll, Jeffrey ;
Gicquel, Brigitte ;
Frothingham, Richard ;
Kreiswirth, Barry N. .
JOURNAL OF INFECTIOUS DISEASES, 2008, 198 (01) :90-94
[4]   Rapid Molecular Detection of Tuberculosis and Rifampin Resistance [J].
Boehme, Catharina C. ;
Nabeta, Pamela ;
Hillemann, Doris ;
Nicol, Mark P. ;
Shenai, Shubhada ;
Krapp, Fiorella ;
Allen, Jenny ;
Tahirli, Rasim ;
Blakemore, Robert ;
Rustomjee, Roxana ;
Milovic, Ana ;
Jones, Martin ;
O'Brien, Sean M. ;
Persing, David H. ;
Ruesch-Gerdes, Sabine ;
Gotuzzo, Eduardo ;
Rodrigues, Camilla ;
Alland, David ;
Perkins, Mark D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (11) :1005-1015
[5]   Drug-resistant tuberculosis: Past, present, future [J].
Chiang, Chen-Yuan ;
Centis, Rosella ;
Migliori, Giovanni Battista .
RESPIROLOGY, 2010, 15 (03) :413-432
[6]   Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa [J].
Gandhi, Neel R. ;
Moll, Anthony ;
Sturm, A. Willem ;
Pawinski, Robert ;
Govender, Thiloshini ;
Lalloo, Umesh ;
Zeller, Kimberly ;
Andrews, Jason ;
Friedland, Gerald .
LANCET, 2006, 368 (9547) :1575-1580
[7]   Treatment Outcome and Mortality among Patients with Multidrug-resistant Tuberculosis in Tuberculosis Hospitals of the Public Sector [J].
Jeon, Doo Soo ;
Shin, Dong Ok ;
Park, Seung Kyu ;
Seo, Jeong Eun ;
Seo, Hae Sook ;
Cho, Young Soo ;
Lee, Joon Young ;
Kim, Dae Yun ;
Kong, Suck Jun ;
Kim, Yun Seong ;
Shim, Tae Sun .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2011, 26 (01) :33-41
[8]   The interval between initiation of anti-tuberculosis treatment in patients with culture-positive pulmonary tuberculosis and receipt of drug-susceptibility test results [J].
Joh, Joon-Sung ;
Lee, Chang Hoon ;
Lee, Ji Eun ;
Park, Young-Kil ;
Bai, Gill-Han ;
Kim, Eui-Chong ;
Han, Sung Koo ;
Shim, Young-Soo ;
Yim, Jae-Joon .
JOURNAL OF KOREAN MEDICAL SCIENCE, 2007, 22 (01) :26-29
[9]  
Korea Centers for Disease Contbl and Prevention, 2010, STAT HIV AIDS INF KO
[10]  
Korea Centers for Disease Control and Prevention, 2009, PUBLIC HLTH WKLY REP, V2, P825